Early-onset cancers are rising among adults 18–49, challenging long-held assumptions about who cancer affects and how patients need to be reached, supported and understood. The New Age of Cancer explores what this shift means for the oncology ecosystem, and why pharma and health marketers may need to rethink the way they engage a generation of patients whose lives, expectations and care journeys look very different from the ones today’s models were built around.
